Macrophage colony-stimulating factor enhances phagocytosis and oxidative burst of mononuclear phagocytes against Penicillium marneffei conidia

FEMS Immunology and Medical Microbiology

Volumn 36, Issue 1-2, 2003, Pages 19-26

  Roilides, Emmanuel ^a,b   Lyman, Caron A ^a   Sein, Tin ^a   Petraitiene, Ruta ^a   Walsh, Thomas J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Macrophage colony stimulating factor; Mononuclear phagocytes; Penicillium marneffei

Indexed keywords

COLONY STIMULATING FACTOR 1; SUPEROXIDE;

AEROBIC METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASPERGILLUS FUMIGATUS; CONIDIUM; CONTROLLED STUDY; CYTOKINE PRODUCTION; ELECTRON MICROSCOPY; FUNGAL STRAIN; FUNGUS ISOLATION; HOST RESISTANCE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG ALVEOLUS MACROPHAGE; LUNG INFECTION; MONOCYTE; MONONUCLEAR PHAGOCYTE; MYCOSIS; NONHUMAN; PENICILLIUM MARNEFFEI; PHAGOCYTOSIS; PRIORITY JOURNAL; RESPIRATORY BURST;

EID: 0037447985     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(03)00035-X     Document Type: Article

References (19)

1. Duong T.A. Infection due to Penicillium marneffei, an emerging pathogen: review of 155 reported cases. Clin. Infect. Dis. 23:1996;125-130.
2. Sirisanthana V., Sirisanthana T. Disseminated Penicillium marneffei infection in human immunodeficiency virus-infected children. Pediatr. Infect. Dis. J. 14:1995;935-940.
3. Cooper C.R.J., McGinnis M.R. Pathology of Penicillium marneffei. An emerging acquired immunodeficiency syndrome-related pathogen. Arch. Pathol. Lab. Med. 121:1997;798-804.
4. Chariyalertsak S., Sirisanthana T., Saengwonloey O., Nelson K.E. Clinical presentation and risk behaviors of patients with acquired immunodeficiency syndrome in Thailand, 1994-1998: regional variation and temporal trends. Clin. Infect. Dis. 32:2001;955-962.
5. Depraetere K., Colebunders R., Ieven M., De Droogh E., Pelgrom Y., Hauben E., Van Marck E., Devroey C. Two imported cases of Penicillium marneffei infection in Belgium. Acta Clin. Belg. 53:1998;255-258.
6. Kok I., Veenstra J., Rietra P.J., Dirks-Go S., Blaauwgeers J.L., Weigel H.M. Disseminated Penicillium marneffei infection as an imported disease in HIV-1 infected patients. Description of two cases and a review of the literature. Neth. J. Med. 44:1994;18-22.
7. Cogliati M., Roverselli A., Boelaert J.R., Taramelli D., Lombardi L., Viviani M.A. Development of an in vitro macrophage system to assess Penicillium marneffei growth and susceptibility to nitric oxide. Infect. Immun. 65:1997;279-284.
8. Rongrungruang Y., Levitz S.M. Interactions of Penicillium marneffei with human leukocytes in vitro. Infect. Immun. 67:1999;4732-4736.
9. Kudeken N., Kawakami K., Saito A. Different susceptibilities of yeasts and conidia of Penicillium marneffei to nitric oxide (NO)-mediated fungicidal activity of murine macrophages. Clin. Exp. Immunol. 112:1998;287-293.
10. Kudeken N., Kawakami K., Saito A. Cytokine-induced fungicidal activity of human polymorphonuclear leukocytes against Penicillium marneffei. FEMS Immunol. Med. Microbiol. 26:1999;115-124.
11. Kudeken N., Kawakami K., Saito A. Role of superoxide anion in the fungicidal activity of murine peritoneal exudate macrophages against Penicillium marneffei. Microbiol. Immunol. 43:1999;323-330.
12. Kudeken N., Kawakami K., Saito A. Mechanisms of the in vitro fungicidal effects of human neutrophils against Penicillium marneffei induced by granulocyte-macrophage colony-stimulating factor (GM-CSF). Clin. Exp. Immunol. 119:2000;472-478.
13. Karbassi A., Becker J.M., Foster J.S., Moore R.N. Enhanced killing of Candida albicans by murine macrophages treated with macrophage colony-stimulating factor: Evidence for augmented expression of mannose receptors. J. Immunol. 139:1987;417-421.
14. Roilides E., Lyman C.A., Mertins S.D., Cole D.J., Venzon D., Pizzo P.A., Chanock S.J., Walsh T.J. Ex vivo effects of macrophage colony-stimulating factor on human monocyte activity against fungal and bacterial pathogens. Cytokine. 8:1996;42-48.
15. Roilides E., Lyman C.A., Sein T., Gonzalez C., Walsh T.J. Antifungal activity of splenic, liver and pulmonary macrophages against Candida albicans and effects of macrophage colony-stimulating factor. Med. Mycol. 38:2000;161-168.
16. Roilides E., Sein T., Holmes A., Blake C., Pizzo P.A., Walsh T.J. Effects of macrophage colony-stimulating factor on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. J. Infect. Dis. 172:1995;1028-1034.
17. Cenci E., Bartocci A., Puccetti P., Mocci S., Stanely E.R., Bistoni F. Macrophage colony-stimulating factor in murine candidiasis: Serum and tissue levels during infection and protective effect of exogenous administration. Infect. Immun. 59:1991;868-872.
18. Roilides E., Tsaparidou S., Kadiltsoglou I., Sein T., Walsh T.J. Interleukin-12 enhances antifungal activity of human mononuclear phagocytes against Aspergillus fumigatus: Implications for an interferon-γ-independent pathway. Infect. Immun. 67:1999;3047-3050.
19. McGinnis M.R., Nordoff N.G., Ryder N.S., Nunn G.B. In vitro comparison of terbinafine and itraconazole against Penicillium marneffei. Antimicrob. Agents Chemother. 44:2000;1407-1408.